Slide deck
par
Oviedo-Joekes, Eugenia
Date de publication
2018
Géographie
Canada
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Non
Évalué par des pairs
No
L’objectif
The aim of this presentation is to examine the safety profile of injectable
hydromorphone and diacetylmorphine by analyzing rates of adverse
events (AEs) in the SALOME study and exploring if they were
associated with dose and patterns of treatment attendance.
Constatations/points à retenir
When injectable hydromorphone and diacetylmorphine are individually dosed and monitored, their opioid-related side effects, including potential fatal overdoses, are safely mitigated and treated by health care providers. Related adverse events did not lead to more missed treatment days and the dose prescribed does not seem to play a direct or sole role.
Mots clés
Safer supply
Evidence base
Overdose
Outcomes
